Doctor Kateryna Sopova
University Medical Centre of Mannheim, Mannheim (Germany)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease
Event: Frontiers in CardioVascular Biomedicine 2024
Topic: Biomarkers
Session: Targets and markers of cardiometabolic disease
Circulating amyloid-beta 1-40 levels associate with cardiac remodelling and myocardial recovery in advanced heart failure
Event: ESC Congress 2023
Topic: Biomarkers
Session: Novel biomarkers in heart failure
Interferon-gamma inducible protein IP-10 and left ventricular remodelling post-acute myocardial infarction: a longitudinal cardiovascular magnetic resonance imaging substudy of CAPRI clinical trial
Event: ESC Congress 2020
Topic: Inflammation and Immunity
Session: Coronary Artery Disease (Chronic) ePosters
Prognostic and reclassification value of serum cathepsin S over the GRACE risk score in patients with non-ST-segment elevation acute coronary syndrome
Event: ESC Congress 2020
Topic: Biomarkers
Session: Risk Factors and Prevention ePosters
Circulating serum extracellular matrix degradation enzyme cathepsin S predicts mortality and improves risk stratification over the GRACE score in patients with non-ST elevation acute coronary syndrom
Event: ESC Congress 2019
Topic: Biomarkers
Session: Non-troponin biomarkers in acute coronary syndromes
ESC 365 is supported by
